| scholarly article | Q13442814 |
| P2093 | author name string | Tobias Eckle | |
| Holger Eltzschig | |||
| Lori Walker | |||
| Stephanie Bonney | |||
| Kelley Brodsky | |||
| Doug Kominsky | |||
| P2860 | cites work | Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. | Q50478911 |
| Prevalent cardiovascular disease, risk factors and selection out of shift work. | Q51798144 | ||
| Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression. | Q52584256 | ||
| Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. | Q54286663 | ||
| S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling. | Q54325092 | ||
| Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. | Q55060856 | ||
| Shift work and cardiovascular disease | Q57224919 | ||
| Circadian rhythm of heart rate variability after acute myocardial infarction and its influence on the prognostic value of heart rate variability | Q68572860 | ||
| Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir | Q69727486 | ||
| Cardiovascular disease and shift work | Q73761809 | ||
| Shift work and cardiovascular disease--from etiologic studies to prevention through scheduling | Q74030581 | ||
| Clock genes are implicated in the human metabolic syndrome | Q80674582 | ||
| Obesity and metabolic syndrome in circadian Clock mutant mice | Q24627935 | ||
| Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes | Q24633002 | ||
| A role for cryptochromes in sleep regulation | Q24797874 | ||
| Coordination of circadian timing in mammals | Q27860673 | ||
| Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium | Q28304462 | ||
| The mammalian clock component PERIOD2 coordinates circadian output by interaction with nuclear receptors | Q28589192 | ||
| PER2 controls lipid metabolism by direct regulation of PPARγ | Q28589406 | ||
| Fasting-induced protein phosphatase 1 regulatory subunit contributes to postprandial blood glucose homeostasis via regulation of hepatic glycogenesis | Q28591340 | ||
| Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock | Q29616363 | ||
| Activation of glycogen synthase in myocardium induced by intermittent hypoxia is much lower in fasted than in fed rats | Q30441700 | ||
| Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo | Q33496725 | ||
| Shift work, risk factors and cardiovascular disease | Q33653152 | ||
| Direct regulation of myocardial triglyceride metabolism by the cardiomyocyte circadian clock. | Q33661472 | ||
| Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock | Q33949726 | ||
| Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia | Q34268301 | ||
| Advances in understanding the peripheral circadian clocks | Q34278723 | ||
| A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice | Q34826208 | ||
| Circadian variation of blood pressure and the vascular response to asynchronous stress | Q35645631 | ||
| The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. | Q35673857 | ||
| Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats | Q35803377 | ||
| The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity | Q35861542 | ||
| Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injury | Q35989587 | ||
| Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines | Q36140475 | ||
| A 12 year prospective study of circulatory disease among Danish shift workers | Q36166452 | ||
| The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease | Q36380101 | ||
| Increased vascular senescence and impaired endothelial progenitor cell function mediated by mutation of circadian gene Per2. | Q37131039 | ||
| Obesity in mice with adipocyte-specific deletion of clock component Arntl. | Q37195570 | ||
| Ischemia and reperfusion--from mechanism to translation | Q37455225 | ||
| The cell biology of acute myocardial ischemia | Q37722967 | ||
| NF-κB, inflammation, and metabolic disease. | Q37825008 | ||
| Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart. | Q37831555 | ||
| The innate immune response in reperfused myocardium | Q37977824 | ||
| Cardiac period 2 in myocardial ischemia: clinical implications of a light dependent protein | Q38071849 | ||
| Gadd45beta is a novel mediator of cardiomyocyte apoptosis induced by ischaemia/hypoxia | Q38488490 | ||
| Clock gene modulation by TNF-alpha depends on calcium and p38 MAP kinase signaling | Q39821981 | ||
| A role of matrix metalloproteinase-8 in atherosclerosis | Q40000765 | ||
| Upregulation of the water channel aquaporin-4 as a potential cause of postischemic cell swelling in a murine model of myocardial infarction | Q40244354 | ||
| Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors | Q42165593 | ||
| Toll-like receptor signaling during myocardial ischemia | Q42713693 | ||
| Resistin-like molecule-beta is an allergen-induced cytokine with inflammatory and remodeling activity in the murine lung | Q42827760 | ||
| Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. | Q43214302 | ||
| Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis | Q43954468 | ||
| Role of protein phosphatases in hypoxic preconditioning | Q44103951 | ||
| Impact of one year of shift work on cardiovascular disease risk factors | Q44973583 | ||
| H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. | Q45255449 | ||
| Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning | Q46509525 | ||
| Impact of ischemia and reperfusion times on myocardial infarct size in mice in vivo | Q46835194 | ||
| When the Clock stops ticking, metabolic syndrome explodes | Q46883072 | ||
| CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury | Q46972080 | ||
| The mPer2 gene encodes a functional component of the mammalian circadian clock | Q47946668 | ||
| Phenotypic rescue of a peripheral clock genetic defect via SCN hierarchical dominance | Q48526746 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| fatty acid | Q61476 | ||
| reperfusion injury | Q1413991 | ||
| Period circadian clock 2 | Q15323263 | ||
| P304 | page(s) | e71493 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Cardiac Per2 functions as novel link between fatty acid metabolism and myocardial inflammation during ischemia and reperfusion injury of the heart | |
| P478 | volume | 8 |
| Q37333867 | ADORA2b Signaling in Cardioprotection |
| Q34152145 | Cardioprotection against ischemia/reperfusion by licochalcone B in isolated rat hearts |
| Q92403195 | Cardioprotective Effects of Sphingosine-1-Phosphate Receptor Immunomodulator FTY720 in a Clinically Relevant Model of Cardioplegic Arrest and Cardiopulmonary Bypass |
| Q27303840 | Cardioprotective Signature of Short-Term Caloric Restriction |
| Q34127839 | Circadian gene variants in cancer. |
| Q27008917 | Circadian influences on myocardial infarction |
| Q35771444 | Circadian rhythms in anesthesia and critical care medicine: potential importance of circadian disruptions |
| Q92084878 | Circadian-Hypoxia Link and its Potential for Treatment of Cardiovascular Disease |
| Q26782018 | Clock genes in hypertension: novel insights from rodent models |
| Q36078415 | Differential Tissue-Specific Function of Adora2b in Cardioprotection |
| Q93144213 | Dose-dependent Effects of Esmolol-epinephrine Combination Therapy in Myocardial Ischemia and Reperfusion Injury |
| Q91964712 | Fingolimod Plays Role in Attenuation of Myocardial Injury Related to Experimental Model of Cardiac Arrest and Extracorporeal Life Support Resuscitation |
| Q88691878 | Genetic variations in circadian rhythm genes and susceptibility for myocardial infarction |
| Q33610660 | Intense light-elicited upregulation of miR-21 facilitates glycolysis and cardioprotection through Per2-dependent mechanisms |
| Q87233663 | Rosiglitazone dampens pulmonary inflammation in a porcine model of acute lung injury |
| Q41063055 | SCA1+ Cells from the Heart Possess a Molecular Circadian Clock and Display Circadian Oscillations in Cellular Functions. |
| Q41665385 | Sphingosine 1-Phosphate Receptor Modulator Fingolimod (FTY720) Attenuates Myocardial Fibrosis in Post-heterotopic Heart Transplantation |
| Q91676255 | The Circadian PER2 Enhancer Nobiletin Reverses the Deleterious Effects of Midazolam in Myocardial Ischemia and Reperfusion Injury |
| Q89683138 | The Impact of the Circadian Genes CLOCK and ARNTL on Myocardial Infarction |
| Q50533803 | The Period 2 Enhancer Nobiletin as Novel Therapy in Murine Models of Circadian Disruption Resembling Delirium. |
| Q41481270 | The circadian clock regulates inflammatory arthritis. |
| Q28084814 | The vascular clock system generates the intrinsic circadian rhythm of vascular contractility |
| Q50552191 | mRNA levels of circadian clock components Bmal1 and Per2 alter independently from dosing time-dependent efficacy of combination treatment with valsartan and amlodipine in spontaneously hypertensive rats. |
Search more.